Home › Sickle Cell Disease › New Jersey
Sickle Cell Disease clinical trials in New Jersey
8 studies for Sickle Cell Disease are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Newark Beth Israel MC, Newark
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 17, 2026 · NCT06612268A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Jack & Sheryl Morris Cancer Center, New Brunswick
- Robert Wood Johnson University Hospital, New Brunswick
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 2/3
Ages 12 and older · All sexes · Updated Aug 18, 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Newark Beth Israel Medical Center - Hemophilia Center, Newark
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Hackensack University Hospital (MRD-HCT), Hackensack
RecruitingObservational study
Ages 3 to 20 · All sexes · Updated Jun 4, 2026 · NCT06941389A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Memorial Sloan Kettering at Basking Ridge (Consent only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only), Middletown
- Memorial Sloan Kettering Bergen (Consent only), Montvale
RecruitingPhase 2
Ages 2 to 50 · All sexes · Updated Jun 3, 2026 · NCT05736419Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
- Site # 8400001, New Brunswick
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Apr 15, 2026 · NCT07247188A Long-term Follow-up Study in Patients Who Received BEAM-101
- Hackensack University Medical Center, Hackensack
RecruitingObservational study
Ages 14 to 37 · All sexes · Updated Jan 28, 2026 · NCT07373639Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- Rutgers New Jersey Medical School, Newark
Recruiting
Ages 16 to 30 · All sexes · Updated Jan 7, 2026 · NCT06374238From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.